Optimizing number of cycles of induction chemotherapy for patients with nasopharyngeal carcinoma: Retrospective survival analysis.
Yan HeZhihao ZhaoYing WangJiamin ChaiJialing HeJing-Jing WangLing HeHui GuanZhigong WeiZhe-Ran LiuXiaoli MuXing-Chen PengPublished in: Head & neck (2020)
Two and three cycles of induction chemotherapy are associated with similar survival, while four cycles reduce survival and increase treatment-related toxicity in endemic regions.